Full Length Research Paper
References
|
Adjidé CC, Meyer A, Weyer M, Obin O, Lamory F, Lesueur C, Trouillet L, Biendo M, Ganry O, Eb F (2009). A sensitive, specific and predictive isolation medium developed for Stenotrophomonas maltophilia study in healthcare settings. Pathologie Biologie 58:11-17. Crossref |
||||
| Akoua KC, Guessennd N, Gbonon V, Faye Ketté H, Dosso M (2004). Methicillin resistance of Staphylococcus in Abidjan 1998-2001: A new problem. Med. Infect. Dis. 34 (3):132-136. | ||||
| Anonymous (2006). Norme NF EN 1040. Antiseptics and chemical disinfection. Quantitative suspension test for the evaluation of bactericidal activity of the basic chemical disinfectants and antiseptics. AFNOR, April. | ||||
|
Arpin C, Dubois V, Coulange L, Andre C, Fisher I, Noury P (2003). Extended-spectrum betalactamases-producing Enterobacteriaceae in community and private heath care centers. Antimicrob. Agents Chemother. 47(11): 3506-14. Crossref |
||||
| Beaucaire G (1997). Nosocomial Infections. Review Prat (Paris), 47:3201. | ||||
|
Ben-Ami R, Schwaber MJ, Navon-Venezia S (2006). Influx of extended-spectrum ß-lactamase producing Enterobacteriaceae into the hospital Clin. Infect. Dis. 42:325-34. Crossref |
||||
|
Bouchillon SK, Johnson BM, Hobana DJ, Johnson JL, Dowzicky MJ, Wu DH, Visalic MA, Bradford PA (2004). Determining incidence of extended spectrum bêta lactamase producing Enterobacteria, Vancomycin-resistant Enterococcus faecium and methicillin resistant Staphylococccusaureus in 38 centers from 17 countries: the PEARLS study 2001-2002. J. Antimicrob. Agents 24:119-124. Crossref |
||||
|
Brigante G, Luzzaro F, Perilli M, Lombardi G, Coli A, Rossolini GM (2005). Evolution of CTX-M type betalactamases in isolates of Escherichia coli infecting hospital and community patients. Int. J. Antimicrob. Agents 25(2):157-62. Crossref |
||||
|
Bronzwaer SL, Cars O, Buchholz U, Molstad S, Goettsch W, Veldhuijzen IK (2002). A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg. Infect. Dis. 8:278-282. Crossref |
||||
| Cady A, Carrer A, Réglier-Poupet H, Fortineau N, Adam JM, Nordmann P, Poyart C (2006). Evaluation of chromID™ ESBL medium for the detection of extended-spectrum beta-lactamase (ESBL) producing enterobacteria. Poster 362 presented at the Meeting Interdiciplinaire Chemotherapy Anti-infectives, Paris (France). | ||||
|
Colodner R, Rock W, Chazan B (2004). Risk factors for the development of extended-spectrum betalactamases-producing bacteria in nonhospitalzed patients. Eur. J. Clin. Microbiol. Infect Dis. 23:163-167. Crossref |
||||
| Comité d'Antibiogramme de la société Française de Microbiologie (CA-SFM) (2012). Available online at www.sfm-microbiologie.org. Consulted 13 November. | ||||
|
De Champs CL (1993). Selective digestive decontamination by erythromycin-base in a polyvalent intensive care unit. Intensive Care Med. 19:191-196. Crossref |
||||
|
Denton M, Kerr KG (1998). Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin. Microbiol Rev. 11(1):57-80. Pubmed |
||||
|
Dosso M, Bissagnene E, Coulibaly M (2000). Acquired resistance and antibiotic prescriptions in Africa: what adequations?. Med. Mal Infec. 30:197-204. Crossref |
||||
|
Dupeyron CM, Guillemin GA, Leluan GJ (1986). Rapid diagnosis of gram negative urinary infections: identification and antimicrobial susceptibility testing in 24 hours. J. Clin. Pathol. 39:208-11. Crossref |
||||
|
Gangoué-Piéboji J, Bedenic B, Koulla-Shiro S, Randegger C, Adiogo D, Ngassam P, Ndumbé P, Hächler H (2005). Extended- Spectrum-β-lactamase-producting Enterbacteriaceae in Yaounde, Cameroon. J. Clin. Microb. 43:3273-3277. Crossref |
||||
|
Guessennd N, Bremont S, Gbonon V, Kacou-NDouba A, Ekaza E, Lambert T, Dosso M, Courvalin P (2008). Qnr-type quinolone resistance in extrended-spectrum beta-lactamase producing enterobacteria in Abidjan, Ivory Coast. Pathologie Biologie 56: 439-446. Crossref |
||||
|
Hélène Réglier-Poupet, Thierry N, Amélie C, Anne C, Jean-Marie A, Nicolas F, Claire P, Patrice N (2008). Performance of chromID ESBL, a chromogenic medium for detection of Enterobacteriaceae producing extended-spectrum ß-lactamases. J. Med. Microbiol. 57:310-315. Crossref |
||||
|
Ho PL, Tsang DNC, Que TL, Ho M, Yuen Y (2000). Comparison of screnning methods for detection of extended beta lactamases and their prevalence among Escherichia coli and klebsiella species in Hong Kong. APMIS, 108:237-240. Crossref |
||||
|
Jarlier V, Nicolas MH, Fournier G, Philippon A (1988). Extended broad-spectrum bêta lactamases conferring transferable resistance to newer beta-lactame agents in Enterobacteria: hospital prevalence and susceptibility pattens. Rev. Infect. Dis. 10:867-878. Crossref |
||||
|
Kim YK, Pai H, Lee HJ, Park SE, Choi EH, Kim J (2002). Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob. Agents Chemother. 46(5):1481-91. Crossref |
||||
|
Komatsu M (2000). Detection of extended spectrum beta-lactamases producing Enterobacteriaceae in feces. Kansenshogaku Zasshi 74:250-258 [Article in Japanese]. Pubmed |
||||
| Livermore DM (1995). β-lactamase mediated resistance: past, present and future. J. Infect. Dis. Sci. 6:75-83. | ||||
|
Livermore DM, Hawkey PM (2005). CTX-M: the changing face of ESBLs in the UK. J. Antimicrob. Chemother. 56 : 451-4. Crossref |
||||
| Sánchez-Carrillo C, Rivera M, Cercenado E, Bouza E (2009). Evaluation of a chromogenic bioMérieux chromID™ ESBL medium for screening and presumptive identification of extended-spectrum ß-lactamase-producing Enterobacteriaceae from surveillance cultures. Poster P2060 presented at the 19th European Congress of Clinical Microbiology and Infectious Diseases, 16-19 Mai, Helsinki (Finlande). | ||||
|
Pai H, Lyu S, Lee JH, Kim J, Kwon Y, Choe JW, Choe KW (1999). Survey of extended spectrum bêta lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea. J. Clin. Microbiol. 37:1758-1763. Pubmed |
||||
|
Paterson DL, Bonomo RA (2005). Extended-spectrum ß-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686. Crossref |
||||
|
Pfaller MA, Segreti J (2006). Overview of the epidemiological profile and laboratory detection of extended-spectrum ß-lactamases. Clin. Infect. Dis. 42 (Suppl 4):S153-S163. Crossref |
||||
|
Pitout JD, Hanson ND, Church DL, Laupland KB (2004). Population-based laboratory surveillance for Escherichiacoli-producing extended-spectrum betalactamases: importance of community isolates with blaCTX-M genes. Clin. Infect. Dis. 38:1736-1741. Crossref |
||||
|
Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D (2004). Community and hospital spread of Escherichiacoli producing CTX-M extended-spectrum bêtalactamases in the UK. J. Antimicrob. Chemother. 54(4):735-743. Crossref |
||||
|
Glupczynski Y, Catherine B, Caroline B, Pierre B (2007). Evaluation of a New Selective Chromogenic Agar Medium for Detection of Extended-Spectrum ß-Lactamase-Producing Enterobacteriaceae. J. Clin. Microbiol. 45(2):501-505. Crossref |
||||
|
Zajc-Satler J, Gragas AZ (1993). Xylose lysine deoxycholate agar for the isolation of Salmonella and Shigella from clinical specimens. Zentralbl. Bakteriol. Orig A 237:196-200 Intensive Care Med. 19(4):191-196. |
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
